{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Rancho Cucamonga",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "77988",
      "recalling_firm": "Amphastar Pharmaceuticals, Inc.",
      "address_1": "11570 6th St",
      "address_2": "N/A",
      "postal_code": "91730-6025",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distributed throughout the United States",
      "recall_number": "D-1124-2017",
      "product_description": "Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL single-dose vials, Rx only, Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA 91730, NDC 0548-9021-00",
      "product_quantity": "637,810 vials",
      "reason_for_recall": "Crystallization: Particulate matter (Ketorolac Calcium Salt) was observed from several lots of retained samples.",
      "recall_initiation_date": "20170815",
      "center_classification_date": "20170829",
      "termination_date": "20190114",
      "report_date": "20170906",
      "code_info": "Lot # XI002A6, XI003A6, Exp 12/17; XI004G6, XI005G6, Exp 6/18; XI007H6, Exp 7/18; XI00816, XI00916, XI01016, XI01116, Exp 8/18; XI012J6, XI013J6, Exp 9/18; XI015K6,  Exp 10/18; XI016L6, Exp 11/18; XL018A7, XI019A7, Exp 12/18; XI020B7, XI021B7,  Exp 1/19; XI022C7, XI023C7, Exp 2/19; XI025D7, Exp 3/19."
    }
  ]
}